Tag: India

NNF Licensed Compound RP0217 for Ocular Diseases Treatment

india pharma
Cresset Discovery Services, provider of contract research services for early phase discovery, is pleased to announce that Narayana Nethralaya Foundation (NNF), which conducts translational ophthalmic ...

Drone to Deliver Drugs to Remote Indian Areas

California-based Zipline will provide on-demand medical assistance through its drone delivery service in India, with the aim to provide instant aid to remote areas. Access to the right medication a...

Eisai Pharma India and Mylan Agreed to Promote TECERIS® in India

Eisai Co., Ltd. announced that Eisai’s subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsidiary Mylan India have entered into a license agreement to promote and distribute the secon...

Zentiva Group to Acquire Sanofi’s Production Facilities in India

Zentiva Group announced a transfer agreement with Sanofi to acquire production facilities in Ankleshwar, India. With this acquisition, Zentiva is expanding its operations and capabilities of its manuf...

Delhi High Court Revoked the Patent on Novartis’ Ceritinib

A key cancer drug is set to get cheaper in India with the Delhi High Court revoking the patent on Swiss pharma major Novartis’ ceritinib, marketed as Zykadia. The Court suspended the earlier interi...

Glenmark Received Regulatory Approval to Market Inhibitor Remogliflozin in India

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, announced that the company has received regulatory approval to market a combination of its novel, patent protect...

Aridis Agreed with the Serum Institute on Exclusive License to Products and MabIgX® Platform

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening ...

Glenmark, Torrent Agreed to Co-Market Remogliflozin Etabonate in India

Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodium glucose co-tra...

Value of the Russian Exports to India Exceeded $1m

At the Round table “Development of bilateral trade, banking and financial sector and industrial cooperation”, which is taking place on the sidelines of the Second Russia-India Strategic Economic Dialo...

First Indian-Chinese Working Group on Pharmaceuticals Will Take Place

India will be sending a high-level delegation to the first meeting of the working group on pharmaceuticals, with China, scheduled in Beijing next month. An initiative under the India-China Strategi...

India’s Biologic Market is Set for Strong Growth in 2019

Findings from CPhI’s bio league tables predict strong growth for India’s biologic market throughout the whole of 2019 in the build-up to CPhI India, which is set to take place later this year in Novem...

India and Cuba aimed to enhance cooperation in biotech and pharma industries

India and Cuba identified new sectors for bilateral cooperation during the recent Havana International Fair, one of the most representative business events in Latin America and the Caribbean.

India and Turkmenistan expanding pharmaceutical partnership

A meeting with an Indian delegation consisting of heads and representatives of about 30 pharmaceutical companies was held at the Union of Industrialists and Entrepreneurs of Turkmenistan. The Union...

Indian pharma manufacturers had a meeting with Russian colleagues

The event was initiated by the Council for promoting the development of export by Indian pharma manufacturers with support from the Ministry of Commerce and Industry of the Government of India.

Piramal Pharma to open its new cGMP kilo lab suite in India

Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization, announced the completion of its new cGMP kilo lab suite at its API site in Ennore (Chennai, India).

Italian API manufacturer buys a production facility in India

Olon, an API contract development and manufacturing organization and generics supplier, announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India.